Your browser doesn't support javascript.
loading
Targeted therapies in hematological malignancies using therapeutic monoclonal antibodies against Eph family receptors.
Charmsaz, Sara; Scott, Andrew M; Boyd, Andrew W.
Afiliación
  • Charmsaz S; Leukaemia Foundation Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, Australia; Department of Medicine, University of Queensland, Brisbane, Australia; Department of Surgery, Royal College of Surgeons, Dublin, Ireland. Electronic address: saracharmsaz@rcsi.ie.
  • Scott AM; Olivia Newton-John Cancer Research Institute, and School of Cancer Medicine, La Trobe University, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.
  • Boyd AW; Leukaemia Foundation Laboratory, QIMR-Berghofer Medical Research Institute, Brisbane, Australia; Department of Medicine, University of Queensland, Brisbane, Australia.
Exp Hematol ; 54: 31-39, 2017 10.
Article en En | MEDLINE | ID: mdl-28751189

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Neoplasias Hematológicas / Receptores de la Familia Eph / Terapia Molecular Dirigida / Anticuerpos Monoclonales / Proteínas de Neoplasias Límite: Humans Idioma: En Revista: Exp Hematol Año: 2017 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Regulación Neoplásica de la Expresión Génica / Neoplasias Hematológicas / Receptores de la Familia Eph / Terapia Molecular Dirigida / Anticuerpos Monoclonales / Proteínas de Neoplasias Límite: Humans Idioma: En Revista: Exp Hematol Año: 2017 Tipo del documento: Article